Evidence map›Paper›PMID 34685891›Full record

ArticlePlants (Basel, Switzerland)2021

Novel Oleanolic Acid-Tryptamine and -Fluorotryptamine Amides: From Adaptogens to Agents Targeting In Vitro Cell Apoptosis.

Uladzimir Bildziukevich, Marie Kvasnicová, David Šaman, Lucie Rárová, Zdeněk Wimmer

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Uladzimir BildziukevichIsotope Laboratory, Institute of Experimental Botany of the Czech Academy of Sciences, Vídeňská 1083, CZ-14220 Prague, Czech Republic.
Marie KvasnicováDepartment of Experimental Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
David ŠamanInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, CZ-16610 Prague, Czech Republic.
Lucie RárováDepartment of Experimental Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.ORCID 0000-0002-3300-007X
Zdeněk WimmerIsotope Laboratory, Institute of Experimental Botany of the Czech Academy of Sciences, Vídeňská 1083, CZ-14220 Prague, Czech Republic.
Czech Academy of Sciences, Institute of Experimental Botany · CZCzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZPalacký University Olomouc · CZ

Funding

European Regional Development Fund CZ.02.1.01/0.0/0.0/16_019/0000738Ministerstvo Průmyslu a Obchodu FV10599Ministerstvo Průmyslu a Obchodu FV30300
6 · The paper itself

Abstract

backgroundOleanolic acid is a natural plant adaptogen, and tryptamine is a natural psychoactive drug. To compare their effects of with the effect of their derivatives, tryptamine and fluorotryptamine amides of oleanolic acid were designed and synthesized.

methodsThe target amides were investigated for their pharmacological effect, and basic supramolecular self-assembly characteristics. Four human cancer cell lines were involved in the screening tests performed by standard methods.

resultsThe ability to display cytotoxicity and to cause selective cell apoptosis in human cervical carcinoma and in human malignant melanoma was seen with the three most active compounds of the prepared series of compounds. Tryptamine amide of (3β)-3-(acetyloxy)olean-12-en-28-oic acid (3a) exhibited cytotoxicity in HeLa cancer cell lines (IC

Indexed as

adaptogenapoptosiscaspasecytotoxicityfluorotryptamineoleanolic acidpsychotropic drugtryptamine

Identifiers

PMID34685891
PMCPMC8540097
OpenAlexW3203149712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.